Open AccessLenvatinib Plus Pembrolizumab Improves Outcomes in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma
Author(s) -
Motzer
Publication year - 2021
Publication title -
journal of clinical outcomes management
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 19
ISSN - 1079-6533
DOI - 10.12788/jcom.0044
Subject(s) - lenvatinib , medicine , pembrolizumab , renal cell carcinoma , oncology , urology , immunotherapy , cancer , sorafenib , hepatocellular carcinoma